Good Morning, Traders!…👋

U.S. stock futures faced pressure on Thursday after President Trump moved forward with new, aggressive tariffs on foreign car imports, raising fears of a full-scale trade war and potential global economic consequences.

On Wednesday, Trump signed an executive order imposing a 25% tariff on foreign-made vehicles, set to take effect on April 2, coinciding with reciprocal tariffs. Stocks fell in anticipation of this announcement, as investors feared it signaled a return to a hardline approach likely to provoke retaliatory actions.

Further stoking concerns, Trump warned on Thursday that even higher tariffs would be imposed on Canada and the EU if they cooperate to harm the U.S. economy. Both of these critical U.S. trade partners have sharply criticized the new tariffs.

Looking ahead, all eyes will be on the release of February's Personal Consumption Expenditures (PCE) Index on Friday, the Federal Reserve's preferred inflation gauge.

Earnings Watch

Quarterly earnings hit today from notable names like Lululemon $LULU ( ▲ 1.12% ), Winnebago $WGO ( ▲ 3.88% ), Braze $BRZE ( ▼ 0.19% ), and Bitfarms $BITF ( ▲ 6.16% ), among others.

Analysts are buzzing with Lululemon expected to post $5.87 EPS (up 11% YoY), Winnebago eyed for a demand rebound, Braze projected at 45% revenue growth, and Bitfarms riding crypto’s hot streak—could these beat forecasts and spark gains?

Happening Today

✓ 08:30 AM ET – Initial Jobless Claims

✓ 08:30 AM ET – GDP (QoQ) & Core PCE Prices (Q4)

✓ 10:00 AM ET – Pending Home Sales (MoM) (Feb)

✓ 01:00 PM ET – 7-Year Note Auction

PREMARKET SNAPSHOT 📈

​As of March 27, 2025, U.S. stock futures are mixed following President Trump's announcement of a 25% tariff on imported cars. This development has particularly impacted auto stocks, with companies like General Motors and Ford experiencing declines in premarket trading.

SECTOR SNAPSHOT✨

Yesterday markets ended the session mixed as defensive sectors like consumer staples, utilities, and real estate showed resilience, while energy and materials also posted modest gains. However, sharp losses in information technology and communication services weighed heavily on sentiment, with consumer discretionary and industrials also under pressure. Financials and health care closed slightly lower, reflecting a cautious tone across most sectors.

PreMarket Unusual Volume Stocks

📈 Greenland Technologies Holding Corporation $GTEC ( ▼ 4.04% )  is seeing explosive pre-market volume with 13.9M shares traded versus its average of 54.1K, a staggering spike of over 25,000%. The stock is up over 86%, suggesting a strong catalyst or speculative interest driving momentum.

📈 Ocean Biomedical, Inc. $OCEA ( ▼ 3.64% )  is surging with 64.12M shares exchanged pre-market compared to an average of 555.3K. Up over 23%, the biotech stock is drawing strong attention, likely tied to news or retail-driven activity.

📈 BioNexus Gene Lab Corp $BGLC ( ▼ 2.65% )  is active early with 6.9M shares traded, sharply higher than its average volume of 124.1K. The stock is up nearly 11%, suggesting renewed interest possibly tied to sector sentiment or announcements.

📈 Lytus Technologies Holdings PTV. Ltd. $LYT ( ▼ 18.56% )  is catching momentum with 111.34M shares traded in the pre-market, well above its 6.34M average. A 99% price jump points to intense speculative interest.

📈 Asset Entities Inc. $ASST ( ▲ 5.77% )  is on the move with 9M shares traded pre-market versus an average of 522.5K. Up nearly 37%, the volume spike signals strong early interest, possibly driven by short-term technical triggers.

Premarket Picks

Greenland Technologies Holding Corporation (GTEC) saw a significant pre-market surge of 68.22%, with its price reaching $2.17. This increase was driven by the company’s fiscal year 2024 net income, which surged to $15.15 million.

Ocean Biomedical, Inc. (OCEA) experienced a pre-market surge of 21.27%, bringing its price to $0.10. The surge followed the company’s filing of an 8-K form with the SEC.

Soleno Therapeutics, Inc. (SLNO) saw its price rise by 34.78%, reaching $66.00 in pre-market trading. This jump was due to the U.S. FDA’s approval of VYKAT™ XR to treat hyperphagia in Prader-Willi Syndrome.

Graphjet Technology (GTI) had a pre-market surge of 15.46%, with its price rising to $0.12. This surge came after the company filed an 8-K form with the SEC.

Below is a complete list of hot stocks in pre-market today:

Top Upgrades:

1. Par Pacific Holdings, Inc. $PARR ( ▲ 3.1% ) 

Analyst Firm: Goldman Sachs
Upgraded: Neutral to Buy
Price Target: $19
Yesterday's Close: $14.23

Goldman Sachs has raised its rating on Par Pacific from Neutral to Buy, increasing the price target from $18 to $19. Par Pacific Holdings, Inc. operates as an energy company in the United States. Analyst price targets for the stock range from a high of $25.00 to a low of $15.00. The median target is set at $20.50, with the average price target coming in at $20.25.

2. Northrop Grumman Corporation $NOC ( ▼ 0.18% )  

Analyst Firm: RBC Capital
Upgraded: Sector Perform to Outperform
Price Target: $575
Yesterday's Close: $507.14

RBC Capital has upgraded Northrop Grumman from Sector Perform to Outperform, revising its price target upward from $500 to $575. Northrop Grumman Corporation is an aerospace and defense technology company serving the U.S., Asia/Pacific, Europe, and other global regions. The stock's price target ranges from a high of $600.00 to a low of $424.00, with a median of $547.00. The average target is $544.05.

3. ING Groep N.V. $ING ( ▲ 0.77% )  

Analyst Firm: Goldman Sachs
Upgraded: Neutral to Buy
Price Target: $24.34
Yesterday's Close: $20.06

Goldman Sachs has upgraded ING Groep from Neutral to Buy, setting a new price target of $24.34. ING Groep N.V. provides banking products and services across the Netherlands, Belgium, Germany, and globally. The stock’s price target has a high of $24.37 and a low of $15.65, with a median target of $19.42. The average target stands at $20.05.

Happy investing,

Maeve Grace
Editor In Chief
Premium Stock Alerts

Important: This newsletter does not provide investment advice. The stocks mentioned should not be taken as recommendations. Your investments are solely your decisions.

Disclosure: I hold no positions in any companies mentioned, either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.